Dexmedetomidine Wound Infiltration in Cesarean Section
Wound Infiltration With Dexmedetomidine in Cesarean Section: Effect on Postoperative Analgesia
Attikon Hospital
100 participants
Aug 23, 2019
INTERVENTIONAL
Conditions
Summary
The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).
Eligibility
Inclusion Criteria1
- pregnancy >37 weeks, ASA I-II, BMI<35
Exclusion Criteria1
- patient refusal, epilepsy, GERD, morbid obesity, drug allergy, ASA class >2, presence of atrioventricular block, severe systemic disease, multiple gestation, high risk pregnancy, contraindications to epidural technique, a history of severe systemic disease, recreational drug or alcohol use
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
WOUND INFILTRATION IN CESAREAN SECTION
WOUND INFILTRATION IN CESAREAN SECTION
WOUND INFILTRATION IN CESAREAN SECTION
placebo WOUND INFILTRATION IN CESAREAN SECTION
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03382938